Nephrol Dial Transplant (1995) 10: 462-467
© 1995 European Renal Association-European Dialysis and Transplant Association
news
The rising tide of endstage renal failure from diabetic nephropathy type II—an epidemiological analysis
Department Internal Medicine Heidelberg, and Dialysepraxis Mannheim-Käfertal Schwetzingen, Weinheim, Germany
In recent years there has been a substantial increase in the proportion of patients requiring renal replacement therapy who suffer from diabetes mellitus. In the lower Neckar region, a survey has been made comprising all patients admitted for renal replacement therapy from 1.1.1993–30.6.1994. Out of a total of 225 patients admitted, 95 suffered from diabetes (10 type I, 85 type II). The estimated annual incidence of terminal renal failure with diabetes was 52/mio/year.
At the same time, 79 patients who suffered from diabetes were admitted to the renal unit in Heidelberg (outpatient clinic and ward) for evaluation of de novo renal failure ({small tilde}176/mio/year); standard primary chronic renal disease was found in 19/79 of these diabetic patients (25%).
The discrepancy between the annual incidence of (i) renal failure and of (ii) terminal renal failure suggests that a high proportion of patients with diabetes (mainly type II) and renal failure, dies prior to reaching terminal renal failure.
Potential reasons for the increasing incidence of endstage renal failure from diabetes type II are (i) the increasing prevalence of type II diabetes in Germany in recent decades, (ii) aging of the population in view of the known greater prevalence of type II diabetes in older individuals and (iii) improved survival of patients with type II diabetes secondary to diminished cardiovascular mortality. Particularly because of the latter factor a further increase of endstage renal failure in patients with type II diabetes must be anticipated.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Schwenger, C. Morath, A. Hofmann, O. Hoffmann, M. Zeier, and E. Ritz Late referral - a major cause of poor outcome in the very elderly dialysis patient Nephrol. Dial. Transplant., April 1, 2006; 21(4): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. S. Leung, W.-Y. So, P. C. Y. Tong, M. K. W. Lo, K.-F. Lee, G. T. C. Ko, W.-B. Chan, C. S. Cockram, B. M. Brenner, S. Shahinfar, et al. The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathy Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2519 - 2525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wimmer, W. Oberaigner, R. Kramar, and G. Mayer Regional variability in the incidence of end-stage renal disease: an epidemiological approach Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1562 - 1567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wimmer, W. Oberaigner, R. Kramar, and G. Mayer Regional variability in the incidence of end-stage renal disease: an epidemiological approach Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1562 - 1567. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. S. Facchini and K. L. Saylor A Low-Iron-Available, Polyphenol-Enriched, Carbohydrate-Restricted Diet to Slow Progression of Diabetic Nephropathy Diabetes, May 1, 2003; 52(5): 1204 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J S. Cameron Fifty years of established diabetic nephropathy -- a personal perspective The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 8 - 16. [PDF]
|
|
|
|
 |
|
 R. Trevisan, M. Vedovato, C. Mazzon, A. Coracina, E. Iori, A. Tiengo, and S. Del Prato Concomitance of Diabetic Retinopathy and Proteinuria Accelerates the Rate of Decline of Kidney Function in Type 2 Diabetic Patients Diabetes Care, November 1, 2002; 25(11): 2026 - 2031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Boucek, F. Saudek, E. Pokorna, S. Vitko, M. Adamec, R. Koznarova, and V. Lanska Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1678 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Joss, K. R Paterson, C. J Deighan, K. Simpson, and J M. Boulton-Jones Vascular disease and survival in patients with type 2 diabetes and nephropathy The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 137 - 142. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Joss, K.R. Paterson, C.J. Deighan, K. Simpson, and J.M. Boulton-Jones Diabetic nephropathy: how effective is treatment in clinical practice? QJM, January 1, 2002; 95(1): 41 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Cordonnier, S. Halimi, and P. Zaoui Survival comparisons in haemodialysis between France and USA. Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2519 - 2520. [Full Text] [PDF]
|
|
|
|
|
|
E.J. Dunn, C.J. Burton, and T.G. Feest The care of patients with diabetic nephropathy: audit, feedback, and improvement QJM, August 1, 1999; 92(8): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.G. Feest, E.J. Dunn, and C.J. Burton Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure? QJM, May 1, 1999; 92(5): 275 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarz, L. Preuschof, and D. Zellner Incidence of analgesic nephropathy in Berlin since 1983 Nephrol. Dial. Transplant., January 1, 1999; 14(1): 109 - 112. [Abstract] [PDF]
|
|
|
|
|
|
F. Chantrel, I. Enache, M. Bouiller, I. Kolb, K. Kunz, P. Petitjean, B. Moulin, and T. Hannedouche Abysmal prognosis of patients with type 2 diabetes entering dialysis Nephrol. Dial. Transplant., January 1, 1999; 14(1): 129 - 136. [Abstract] [PDF]
|
|